nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2B6—Rifampicin—leprosy	0.122	0.152	CbGbCtD
Sertraline—CYP2C19—Thalidomide—leprosy	0.0803	0.0995	CbGbCtD
Sertraline—CYP2C19—Rifampicin—leprosy	0.0778	0.0964	CbGbCtD
Sertraline—CYP1A2—Thalidomide—leprosy	0.0741	0.0918	CbGbCtD
Sertraline—CYP1A2—Rifampicin—leprosy	0.0718	0.089	CbGbCtD
Sertraline—CYP2C9—Thalidomide—leprosy	0.0668	0.0828	CbGbCtD
Sertraline—CYP2C9—Rifampicin—leprosy	0.0647	0.0801	CbGbCtD
Sertraline—CYP2C19—Dapsone—leprosy	0.0642	0.0796	CbGbCtD
Sertraline—ABCB1—Rifampicin—leprosy	0.0628	0.0778	CbGbCtD
Sertraline—CYP2C9—Dapsone—leprosy	0.0534	0.0662	CbGbCtD
Sertraline—CYP3A4—Rifampicin—leprosy	0.0376	0.0466	CbGbCtD
Sertraline—CYP3A4—Dapsone—leprosy	0.031	0.0385	CbGbCtD
Sertraline—Lupus-like syndrome—Dapsone—leprosy	0.00906	0.0469	CcSEcCtD
Sertraline—Inner ear disorder—Thalidomide—leprosy	0.00872	0.0452	CcSEcCtD
Sertraline—Labyrinthine disorder—Thalidomide—leprosy	0.00872	0.0452	CcSEcCtD
Sertraline—Enuresis—Thalidomide—leprosy	0.00383	0.0198	CcSEcCtD
Sertraline—Suicide attempt—Dapsone—leprosy	0.00376	0.0195	CcSEcCtD
Sertraline—Lacrimal disorder—Thalidomide—leprosy	0.00245	0.0127	CcSEcCtD
Sertraline—Hyporeflexia—Thalidomide—leprosy	0.00241	0.0125	CcSEcCtD
Sertraline—Hernia—Thalidomide—leprosy	0.00233	0.0121	CcSEcCtD
Sertraline—Aphthous stomatitis—Thalidomide—leprosy	0.00233	0.0121	CcSEcCtD
Sertraline—Hostility—Thalidomide—leprosy	0.00197	0.0102	CcSEcCtD
Sertraline—Sexual dysfunction—Thalidomide—leprosy	0.00195	0.0101	CcSEcCtD
Sertraline—Suicide attempt—Thalidomide—leprosy	0.00193	0.00998	CcSEcCtD
Sertraline—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00188	0.00974	CcSEcCtD
Sertraline—Enlargement abdomen—Thalidomide—leprosy	0.00182	0.00941	CcSEcCtD
Sertraline—Hypothyroidism—Thalidomide—leprosy	0.0017	0.00882	CcSEcCtD
Sertraline—Galactorrhoea—Thalidomide—leprosy	0.00169	0.00873	CcSEcCtD
Sertraline—Menstrual disorder—Thalidomide—leprosy	0.0016	0.00831	CcSEcCtD
Sertraline—Hepatomegaly—Thalidomide—leprosy	0.00154	0.008	CcSEcCtD
Sertraline—Metrorrhagia—Thalidomide—leprosy	0.00153	0.00793	CcSEcCtD
Sertraline—Nystagmus—Thalidomide—leprosy	0.00153	0.00793	CcSEcCtD
Sertraline—Psychotic disorder—Dapsone—leprosy	0.00151	0.00784	CcSEcCtD
Sertraline—Stupor—Thalidomide—leprosy	0.00146	0.00758	CcSEcCtD
Sertraline—Neuritis—Thalidomide—leprosy	0.00146	0.00758	CcSEcCtD
Sertraline—Hyperaesthesia—Thalidomide—leprosy	0.00139	0.00721	CcSEcCtD
Sertraline—Rash pustular—Thalidomide—leprosy	0.00137	0.0071	CcSEcCtD
Sertraline—Muscular weakness—Dapsone—leprosy	0.00137	0.00708	CcSEcCtD
Sertraline—Endocrine disorder—Thalidomide—leprosy	0.00132	0.00683	CcSEcCtD
Sertraline—Pancreatitis—Dapsone—leprosy	0.00131	0.0068	CcSEcCtD
Sertraline—Apnoea—Thalidomide—leprosy	0.00129	0.00668	CcSEcCtD
Sertraline—Vasodilation procedure—Thalidomide—leprosy	0.00124	0.00644	CcSEcCtD
Sertraline—Amenorrhoea—Thalidomide—leprosy	0.00124	0.00644	CcSEcCtD
Sertraline—Vasodilation—Thalidomide—leprosy	0.00124	0.00644	CcSEcCtD
Sertraline—Photosensitivity reaction—Dapsone—leprosy	0.00122	0.00633	CcSEcCtD
Sertraline—Skin discolouration—Thalidomide—leprosy	0.00121	0.00627	CcSEcCtD
Sertraline—Arthropathy—Thalidomide—leprosy	0.0012	0.00623	CcSEcCtD
Sertraline—Thinking abnormal—Thalidomide—leprosy	0.00119	0.00619	CcSEcCtD
Sertraline—Oliguria—Thalidomide—leprosy	0.00119	0.00614	CcSEcCtD
Sertraline—Neuropathy peripheral—Dapsone—leprosy	0.00117	0.00607	CcSEcCtD
Sertraline—Dyskinesia—Thalidomide—leprosy	0.00116	0.00603	CcSEcCtD
Sertraline—Hypercholesterolaemia—Thalidomide—leprosy	0.00116	0.00599	CcSEcCtD
Sertraline—Atrioventricular block—Thalidomide—leprosy	0.00113	0.00584	CcSEcCtD
Sertraline—Sinusitis—Dapsone—leprosy	0.00112	0.00581	CcSEcCtD
Sertraline—Gait disturbance—Thalidomide—leprosy	0.00112	0.0058	CcSEcCtD
Sertraline—Coordination abnormal—Thalidomide—leprosy	0.00111	0.00577	CcSEcCtD
Sertraline—Phosphatase alkaline increased—Thalidomide—leprosy	0.00109	0.00566	CcSEcCtD
Sertraline—Eructation—Thalidomide—leprosy	0.00107	0.00556	CcSEcCtD
Sertraline—Pharyngitis—Dapsone—leprosy	0.00106	0.00551	CcSEcCtD
Sertraline—Depressed level of consciousness—Thalidomide—leprosy	0.00106	0.00547	CcSEcCtD
Sertraline—Colitis—Thalidomide—leprosy	0.00105	0.00544	CcSEcCtD
Sertraline—Aplastic anaemia—Thalidomide—leprosy	0.00103	0.00532	CcSEcCtD
Sertraline—Cramps of lower extremities—Thalidomide—leprosy	0.001	0.0052	CcSEcCtD
Sertraline—Tinnitus—Dapsone—leprosy	0.001	0.00518	CcSEcCtD
Sertraline—Oesophagitis—Thalidomide—leprosy	0.000999	0.00517	CcSEcCtD
Sertraline—Rash maculo-papular—Thalidomide—leprosy	0.000994	0.00515	CcSEcCtD
Sertraline—Gynaecomastia—Thalidomide—leprosy	0.000978	0.00507	CcSEcCtD
Sertraline—Hypertonia—Thalidomide—leprosy	0.000958	0.00496	CcSEcCtD
Sertraline—Hyperkinesia—Thalidomide—leprosy	0.000954	0.00494	CcSEcCtD
Sertraline—Mental disability—Thalidomide—leprosy	0.000949	0.00491	CcSEcCtD
Sertraline—Euphoric mood—Thalidomide—leprosy	0.000939	0.00487	CcSEcCtD
Sertraline—Erythema—Dapsone—leprosy	0.000934	0.00484	CcSEcCtD
Sertraline—Lymphadenopathy—Thalidomide—leprosy	0.00093	0.00482	CcSEcCtD
Sertraline—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000912	0.00473	CcSEcCtD
Sertraline—Diabetes mellitus—Thalidomide—leprosy	0.000912	0.00473	CcSEcCtD
Sertraline—Photosensitivity—Thalidomide—leprosy	0.000904	0.00468	CcSEcCtD
Sertraline—Gastroenteritis—Thalidomide—leprosy	0.000895	0.00464	CcSEcCtD
Sertraline—Vascular purpura—Thalidomide—leprosy	0.000887	0.0046	CcSEcCtD
Sertraline—Eczema—Thalidomide—leprosy	0.000883	0.00457	CcSEcCtD
Sertraline—Eye pain—Thalidomide—leprosy	0.000879	0.00455	CcSEcCtD
Sertraline—Renal failure acute—Thalidomide—leprosy	0.00086	0.00445	CcSEcCtD
Sertraline—Libido decreased—Thalidomide—leprosy	0.000856	0.00443	CcSEcCtD
Sertraline—Increased appetite—Thalidomide—leprosy	0.000845	0.00438	CcSEcCtD
Sertraline—Amnesia—Thalidomide—leprosy	0.000845	0.00438	CcSEcCtD
Sertraline—Vertigo—Dapsone—leprosy	0.000839	0.00434	CcSEcCtD
Sertraline—Dermatitis bullous—Thalidomide—leprosy	0.00083	0.0043	CcSEcCtD
Sertraline—Purpura—Thalidomide—leprosy	0.000823	0.00426	CcSEcCtD
Sertraline—Cough—Dapsone—leprosy	0.000815	0.00422	CcSEcCtD
Sertraline—Hypoglycaemia—Thalidomide—leprosy	0.000813	0.00421	CcSEcCtD
Sertraline—Hyponatraemia—Thalidomide—leprosy	0.000797	0.00413	CcSEcCtD
Sertraline—Diplopia—Thalidomide—leprosy	0.000794	0.00411	CcSEcCtD
Sertraline—Osteoarthritis—Thalidomide—leprosy	0.000794	0.00411	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000794	0.00411	CcSEcCtD
Sertraline—Disturbance in sexual arousal—Thalidomide—leprosy	0.000787	0.00408	CcSEcCtD
Sertraline—Migraine—Thalidomide—leprosy	0.000781	0.00405	CcSEcCtD
Sertraline—Affect lability—Thalidomide—leprosy	0.000781	0.00405	CcSEcCtD
Sertraline—Psychotic disorder—Thalidomide—leprosy	0.000775	0.00401	CcSEcCtD
Sertraline—Face oedema—Thalidomide—leprosy	0.000766	0.00397	CcSEcCtD
Sertraline—Mood swings—Thalidomide—leprosy	0.000752	0.00389	CcSEcCtD
Sertraline—Ataxia—Thalidomide—leprosy	0.000746	0.00387	CcSEcCtD
Sertraline—Tachycardia—Dapsone—leprosy	0.000744	0.00385	CcSEcCtD
Sertraline—Dehydration—Thalidomide—leprosy	0.000738	0.00382	CcSEcCtD
Sertraline—Dry skin—Thalidomide—leprosy	0.000727	0.00377	CcSEcCtD
Sertraline—Orthostatic hypotension—Thalidomide—leprosy	0.000725	0.00375	CcSEcCtD
Sertraline—Breast disorder—Thalidomide—leprosy	0.000717	0.00371	CcSEcCtD
Sertraline—Cramp muscle—Thalidomide—leprosy	0.000715	0.0037	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000715	0.0037	CcSEcCtD
Sertraline—Muscular weakness—Thalidomide—leprosy	0.0007	0.00363	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Thalidomide—leprosy	0.0007	0.00363	CcSEcCtD
Sertraline—Abdominal distension—Thalidomide—leprosy	0.000691	0.00358	CcSEcCtD
Sertraline—Insomnia—Dapsone—leprosy	0.000689	0.00357	CcSEcCtD
Sertraline—Dysphagia—Thalidomide—leprosy	0.000686	0.00355	CcSEcCtD
Sertraline—Bronchospasm—Thalidomide—leprosy	0.000675	0.00349	CcSEcCtD
Sertraline—Pancreatitis—Thalidomide—leprosy	0.000673	0.00348	CcSEcCtD
Sertraline—Bronchitis—Thalidomide—leprosy	0.00066	0.00342	CcSEcCtD
Sertraline—Pancytopenia—Thalidomide—leprosy	0.000651	0.00337	CcSEcCtD
Sertraline—Upper respiratory tract infection—Thalidomide—leprosy	0.000638	0.0033	CcSEcCtD
Sertraline—Pollakiuria—Thalidomide—leprosy	0.000634	0.00328	CcSEcCtD
Sertraline—Erectile dysfunction—Thalidomide—leprosy	0.000632	0.00327	CcSEcCtD
Sertraline—Photosensitivity reaction—Thalidomide—leprosy	0.000626	0.00324	CcSEcCtD
Sertraline—Weight increased—Thalidomide—leprosy	0.000624	0.00323	CcSEcCtD
Sertraline—Gastrointestinal pain—Dapsone—leprosy	0.000623	0.00323	CcSEcCtD
Sertraline—Weight decreased—Thalidomide—leprosy	0.000621	0.00321	CcSEcCtD
Sertraline—Hyperglycaemia—Thalidomide—leprosy	0.000619	0.0032	CcSEcCtD
Sertraline—Drowsiness—Thalidomide—leprosy	0.000612	0.00317	CcSEcCtD
Sertraline—Depression—Thalidomide—leprosy	0.00061	0.00316	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000606	0.00314	CcSEcCtD
Sertraline—Acute coronary syndrome—Thalidomide—leprosy	0.000603	0.00312	CcSEcCtD
Sertraline—Abdominal pain—Dapsone—leprosy	0.000602	0.00312	CcSEcCtD
Sertraline—Body temperature increased—Dapsone—leprosy	0.000602	0.00312	CcSEcCtD
Sertraline—Neuropathy peripheral—Thalidomide—leprosy	0.0006	0.00311	CcSEcCtD
Sertraline—Myocardial infarction—Thalidomide—leprosy	0.0006	0.00311	CcSEcCtD
Sertraline—Stomatitis—Thalidomide—leprosy	0.000596	0.00309	CcSEcCtD
Sertraline—Conjunctivitis—Thalidomide—leprosy	0.000594	0.00308	CcSEcCtD
Sertraline—Sweating—Thalidomide—leprosy	0.000586	0.00304	CcSEcCtD
Sertraline—Haematuria—Thalidomide—leprosy	0.000583	0.00302	CcSEcCtD
Sertraline—Epistaxis—Thalidomide—leprosy	0.000577	0.00299	CcSEcCtD
Sertraline—Sinusitis—Thalidomide—leprosy	0.000574	0.00297	CcSEcCtD
Sertraline—Agranulocytosis—Thalidomide—leprosy	0.000571	0.00296	CcSEcCtD
Sertraline—Bradycardia—Thalidomide—leprosy	0.000559	0.0029	CcSEcCtD
Sertraline—Rhinitis—Thalidomide—leprosy	0.00055	0.00285	CcSEcCtD
Sertraline—Hepatitis—Thalidomide—leprosy	0.000549	0.00284	CcSEcCtD
Sertraline—Hypoaesthesia—Thalidomide—leprosy	0.000546	0.00283	CcSEcCtD
Sertraline—Pharyngitis—Thalidomide—leprosy	0.000545	0.00282	CcSEcCtD
Sertraline—Urinary tract disorder—Thalidomide—leprosy	0.000542	0.00281	CcSEcCtD
Sertraline—Oedema peripheral—Thalidomide—leprosy	0.000541	0.0028	CcSEcCtD
Sertraline—Urethral disorder—Thalidomide—leprosy	0.000538	0.00279	CcSEcCtD
Sertraline—Visual impairment—Thalidomide—leprosy	0.000529	0.00274	CcSEcCtD
Sertraline—Erythema multiforme—Thalidomide—leprosy	0.000519	0.00269	CcSEcCtD
Sertraline—Eye disorder—Thalidomide—leprosy	0.000513	0.00266	CcSEcCtD
Sertraline—Tinnitus—Thalidomide—leprosy	0.000512	0.00265	CcSEcCtD
Sertraline—Cardiac disorder—Thalidomide—leprosy	0.00051	0.00264	CcSEcCtD
Sertraline—Angiopathy—Thalidomide—leprosy	0.000498	0.00258	CcSEcCtD
Sertraline—Immune system disorder—Thalidomide—leprosy	0.000496	0.00257	CcSEcCtD
Sertraline—Mediastinal disorder—Thalidomide—leprosy	0.000495	0.00256	CcSEcCtD
Sertraline—Chills—Thalidomide—leprosy	0.000493	0.00255	CcSEcCtD
Sertraline—Arrhythmia—Thalidomide—leprosy	0.00049	0.00254	CcSEcCtD
Sertraline—Alopecia—Thalidomide—leprosy	0.000485	0.00251	CcSEcCtD
Sertraline—Vomiting—Dapsone—leprosy	0.000484	0.00251	CcSEcCtD
Sertraline—Mental disorder—Thalidomide—leprosy	0.000481	0.00249	CcSEcCtD
Sertraline—Malnutrition—Thalidomide—leprosy	0.000478	0.00248	CcSEcCtD
Sertraline—Headache—Dapsone—leprosy	0.000477	0.00247	CcSEcCtD
Sertraline—Flatulence—Thalidomide—leprosy	0.000471	0.00244	CcSEcCtD
Sertraline—Tension—Thalidomide—leprosy	0.000469	0.00243	CcSEcCtD
Sertraline—Dysgeusia—Thalidomide—leprosy	0.000468	0.00242	CcSEcCtD
Sertraline—Nervousness—Thalidomide—leprosy	0.000464	0.0024	CcSEcCtD
Sertraline—Back pain—Thalidomide—leprosy	0.000462	0.00239	CcSEcCtD
Sertraline—Muscle spasms—Thalidomide—leprosy	0.00046	0.00238	CcSEcCtD
Sertraline—Nausea—Dapsone—leprosy	0.000453	0.00234	CcSEcCtD
Sertraline—Tremor—Thalidomide—leprosy	0.000448	0.00232	CcSEcCtD
Sertraline—Ill-defined disorder—Thalidomide—leprosy	0.000443	0.0023	CcSEcCtD
Sertraline—Anaemia—Thalidomide—leprosy	0.000442	0.00229	CcSEcCtD
Sertraline—Agitation—Thalidomide—leprosy	0.000439	0.00227	CcSEcCtD
Sertraline—Angioedema—Thalidomide—leprosy	0.000437	0.00226	CcSEcCtD
Sertraline—Malaise—Thalidomide—leprosy	0.000431	0.00223	CcSEcCtD
Sertraline—Vertigo—Thalidomide—leprosy	0.000429	0.00222	CcSEcCtD
Sertraline—Syncope—Thalidomide—leprosy	0.000429	0.00222	CcSEcCtD
Sertraline—Leukopenia—Thalidomide—leprosy	0.000428	0.00222	CcSEcCtD
Sertraline—Palpitations—Thalidomide—leprosy	0.000422	0.00219	CcSEcCtD
Sertraline—Loss of consciousness—Thalidomide—leprosy	0.00042	0.00218	CcSEcCtD
Sertraline—Cough—Thalidomide—leprosy	0.000417	0.00216	CcSEcCtD
Sertraline—Convulsion—Thalidomide—leprosy	0.000414	0.00214	CcSEcCtD
Sertraline—Hypertension—Thalidomide—leprosy	0.000413	0.00214	CcSEcCtD
Sertraline—Chest pain—Thalidomide—leprosy	0.000407	0.00211	CcSEcCtD
Sertraline—Myalgia—Thalidomide—leprosy	0.000407	0.00211	CcSEcCtD
Sertraline—Arthralgia—Thalidomide—leprosy	0.000407	0.00211	CcSEcCtD
Sertraline—Anxiety—Thalidomide—leprosy	0.000405	0.0021	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000404	0.00209	CcSEcCtD
Sertraline—Discomfort—Thalidomide—leprosy	0.000402	0.00208	CcSEcCtD
Sertraline—Dry mouth—Thalidomide—leprosy	0.000398	0.00206	CcSEcCtD
Sertraline—Confusional state—Thalidomide—leprosy	0.000393	0.00204	CcSEcCtD
Sertraline—Oedema—Thalidomide—leprosy	0.00039	0.00202	CcSEcCtD
Sertraline—Shock—Thalidomide—leprosy	0.000384	0.00199	CcSEcCtD
Sertraline—Nervous system disorder—Thalidomide—leprosy	0.000383	0.00198	CcSEcCtD
Sertraline—Thrombocytopenia—Thalidomide—leprosy	0.000382	0.00198	CcSEcCtD
Sertraline—Tachycardia—Thalidomide—leprosy	0.000381	0.00197	CcSEcCtD
Sertraline—Skin disorder—Thalidomide—leprosy	0.000379	0.00196	CcSEcCtD
Sertraline—Hyperhidrosis—Thalidomide—leprosy	0.000377	0.00195	CcSEcCtD
Sertraline—Anorexia—Thalidomide—leprosy	0.000372	0.00193	CcSEcCtD
Sertraline—Hypotension—Thalidomide—leprosy	0.000364	0.00189	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Thalidomide—leprosy	0.000355	0.00184	CcSEcCtD
Sertraline—Insomnia—Thalidomide—leprosy	0.000353	0.00183	CcSEcCtD
Sertraline—Paraesthesia—Thalidomide—leprosy	0.00035	0.00181	CcSEcCtD
Sertraline—Dyspnoea—Thalidomide—leprosy	0.000348	0.0018	CcSEcCtD
Sertraline—Somnolence—Thalidomide—leprosy	0.000347	0.0018	CcSEcCtD
Sertraline—Dyspepsia—Thalidomide—leprosy	0.000343	0.00178	CcSEcCtD
Sertraline—Decreased appetite—Thalidomide—leprosy	0.000339	0.00176	CcSEcCtD
Sertraline—Gastrointestinal disorder—Thalidomide—leprosy	0.000337	0.00174	CcSEcCtD
Sertraline—Fatigue—Thalidomide—leprosy	0.000336	0.00174	CcSEcCtD
Sertraline—Pain—Thalidomide—leprosy	0.000334	0.00173	CcSEcCtD
Sertraline—Constipation—Thalidomide—leprosy	0.000334	0.00173	CcSEcCtD
Sertraline—Feeling abnormal—Thalidomide—leprosy	0.000321	0.00166	CcSEcCtD
Sertraline—Gastrointestinal pain—Thalidomide—leprosy	0.000319	0.00165	CcSEcCtD
Sertraline—Urticaria—Thalidomide—leprosy	0.00031	0.00161	CcSEcCtD
Sertraline—Abdominal pain—Thalidomide—leprosy	0.000308	0.0016	CcSEcCtD
Sertraline—Body temperature increased—Thalidomide—leprosy	0.000308	0.0016	CcSEcCtD
Sertraline—Hypersensitivity—Thalidomide—leprosy	0.000287	0.00149	CcSEcCtD
Sertraline—Asthenia—Thalidomide—leprosy	0.00028	0.00145	CcSEcCtD
Sertraline—Pruritus—Thalidomide—leprosy	0.000276	0.00143	CcSEcCtD
Sertraline—Diarrhoea—Thalidomide—leprosy	0.000267	0.00138	CcSEcCtD
Sertraline—Dizziness—Thalidomide—leprosy	0.000258	0.00134	CcSEcCtD
Sertraline—Vomiting—Thalidomide—leprosy	0.000248	0.00128	CcSEcCtD
Sertraline—Rash—Thalidomide—leprosy	0.000246	0.00127	CcSEcCtD
Sertraline—Dermatitis—Thalidomide—leprosy	0.000246	0.00127	CcSEcCtD
Sertraline—Headache—Thalidomide—leprosy	0.000244	0.00127	CcSEcCtD
Sertraline—Nausea—Thalidomide—leprosy	0.000232	0.0012	CcSEcCtD
